知镜 Cognispect · 医学文献与研究工作台

Efficacy of Voice Therapy Combined with Photobiomodulation in Women with Behavioral Dysphonia: A Triple-Blind Randomized Controlled Trial.

Santana ÉR, Moraes RM, Johnson AM, Ribeiro VV, Torres RVNA, Dias SS, Silva ACFD, Santos ALP, Paiva GM, Anjos PVSD, Castro ÉGDS, Melo ECM, Bastos RSA, Souza RC, Lopes LW.
Journal of voice : official journal of the Voice Foundation · 2026-11-04 · PMID 42982684

文献摘要

Objectives To investigate whether active low-level laser therapy (LLLT) provides an incremental effect as an adjunct to a comprehensive voice therapy (VT) program, compared to VT combined with a placebo laser therapy (PLT), in women with dysphonia. Methods This prospective, parallel-group, triple-blind, placebo-controlled clinical trial enrolled 46 women (18-60 years), with 39 completing the 8-week per-protocol analysis (VT-LLLT n = 22; VT-PLT n = 17). The experimental group received infrared LLLT (808 nm, 100 mW, 30 J) prior to VT, while the control group received a placebo laser. The primary outcome was the auditory-perceptual overall severity (OS) of dysphonia. Secondary outcomes included acoustic measures, vocal self-assessment, and laryngeal videostroboscopic parameters. Results Both groups demonstrated significant pre-to-post improvements across auditory-perceptual, self-assessment, and acoustic parameters, with no statistically significant Group × Time interaction for the primary outcome (OS) or any secondary functional variable. Conversely, laryngeal imaging evaluated via Generalized Linear Models (GLM) revealed a statistically significant Group × Time interaction for the recovery of the vocal fold edge contour (P = 0.005), indicating a localized morphological improvement in the VT-LLLT group. No adverse events were associated with the interventions. Conclusion Although adjunctive active LLLT significantly accelerates the localized macroscopic restoration of the vocal fold edge contour, this structural change does not translate into superior functional, acoustic, or perceptual voice outcomes compared to placebo. Behavioral VT unequivocally remains the primary and dominant therapeutic driver for functional vocal recovery in women with dysphonia.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。